These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke. Docagne F; Parcq J; Lijnen R; Ali C; Vivien D Stroke; 2015 Jan; 46(1):314-20. PubMed ID: 25395410 [No Abstract] [Full Text] [Related]
13. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy in stroke]. Kaste M Duodecim; 1995; 111(20):1907-9. PubMed ID: 9841140 [No Abstract] [Full Text] [Related]
15. [Tissue plasminogen activator is the best thrombolytic agent]. Bates E Arq Bras Cardiol; 1994 Jul; 63(1):57-8. PubMed ID: 7857215 [No Abstract] [Full Text] [Related]
16. Thrombolysis for acute stroke: a new era in treatment. Gress DR; Bonovich D Am Fam Physician; 1997 Jun; 55(8):2590-1. PubMed ID: 9191443 [No Abstract] [Full Text] [Related]
17. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis. Hiatt MD Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680 [TBL] [Abstract][Full Text] [Related]
18. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. GUSTO investigators N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123 [TBL] [Abstract][Full Text] [Related]
19. Thrombolysis after stroke. Fieschi C; Toni D Lancet; 1996 Oct; 348(9033):1035. PubMed ID: 8855886 [No Abstract] [Full Text] [Related]
20. Randomised trials of endovascular treatment of stroke are needed. Schott AM Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032 [No Abstract] [Full Text] [Related] [Next] [New Search]